<div class="pk-crumbs" data-crumbs="[{&quot;label&quot;:&quot;Drugs&quot;,&quot;href&quot;:&quot;README.md&quot;},{&quot;label&quot;:&quot;B01A&quot;,&quot;href&quot;:&quot;atc/B01A.md&quot;},{&quot;label&quot;:&quot;nadroparin&quot;,&quot;href&quot;:&quot;drugs/drug_nadroparin/&quot;},{&quot;label&quot;:&quot;Chen_2024 \u00b7 reference&quot;}]"></div>
<div class="pk-recnav" data-items="[{&quot;id&quot;:&quot;Nadroparin_Piwowarczyk2023_reference&quot;,&quot;label&quot;:&quot;Piwowarczyk_2023_reference&quot;,&quot;group&quot;:&quot;popPK&quot;,&quot;href&quot;:&quot;drugs/drug_nadroparin/Nadroparin_Piwowarczyk2023_reference.md&quot;,&quot;status&quot;:&quot;Not simulated \u00b7 stale&quot;,&quot;css&quot;:&quot;pk-badge--neutral&quot;,&quot;here&quot;:false}]"></div>

<div class="pk-tab-mark" data-tab="Information"></div>

# nadroparin — `Nadroparin_Chen2024_reference`

> ## <span class="pk-badge pk-badge--neutral">Not simulated</span> <span class="pk-badge pk-badge--stale">stale</span>

> This record was reviewed on 2026-09-28 14:39 UTC (Needs review), but the paper was screened again on 2026-10-07 18:12 UTC, so that review may no longer match the record. Until it is reviewed again, the status shown comes from the automatic checks.

<div class="pk-model-meta" hidden drug="nadroparin" model-id="Nadroparin_Chen2024_reference" status="extracted" stale="true" population="neonates and infants less than 8 months" measured-compound="anti-Xa" parameterization="apparent" topology="1C"></div>

## Citation
Chen Y, Lan J, Zhu L, Dong M, Wang Y, Li Z. Is the current therapeutic dosage of nadroparin adequate for neonates and infants under 8 months with thromboembolic disease? a population pharmacokinetic study from a national children's medical center. Frontiers in pharmacology 15:1331673 (2024).
  ·  DOI: [10.3389/fphar.2024.1331673](https://doi.org/10.3389/fphar.2024.1331673)

## Population and dosing

**Population:** neonates and infants less than 8 months · condition thromboembolic disease · age group neonate · n = 40.

**Dosing:** 150, 200 IU/kg, sc, multiple, every 12 h.

**Dosed compound ≠ measured compound:** dosed nadroparin, measured anti-Xa.

## Model

**Structure:** 1-compartment, oral mammillary model — template `PK_1C_enteral`.  
**Parameterization:** CL/F, V/F — apparent, F unknown (apparent — bioavailability not identifiable).  
**Parameters:** 3 extracted.  
**Availability:** Model withheld: a core parameter is unspecified.

## Parameters
| label | parameter | value | unit | IIV |
|---|---|---|---|---|
| CL/F (L/h) | CL/F | 0.211 | L/h | 26.5 (None% RSE) |
| Vd/F (L) | V/F | 1.55 | L |  |
| ka (h-1) | kabs | 0.495 | h-1 |  |

<details class="pk-evidence"><summary>Evidence &amp; review</summary>

**Status and checks:** <span class="pk-badge pk-badge--neutral">Not simulated</span> <span class="pk-badge pk-badge--stale">stale</span> <span class="pk-badge pk-badge--red" title="re-read by gpt-oss-120b (not confirmed, agreement 0.857). Primary extraction retained.">cross-check: disputed</span>

<details class="legend">
<summary>Status and cross-check definitions</summary>
<table><thead><tr><th>Badge</th><th>Definition</th></tr></thead><tbody><tr><td><span class="pk-badge pk-badge--green">Curated (human-checked)</span></td><td>Authored or checked by a person against the paper.</td></tr><tr><td><span class="pk-badge pk-badge--green">Reproduces paper</span></td><td>The model built from the extracted parameters reproduces the paper's reported reference values; not human-verified.</td></tr><tr><td><span class="pk-badge pk-badge--green">Reproduces with caveats</span></td><td>Reproduces the paper's reference values, but an advisory check is open (for example, covariate scenarios not evaluated).</td></tr><tr><td><span class="pk-badge pk-badge--neutral">Not simulated</span></td><td>Extracted and checked against closed-form rules, but no simulation has compared it with the paper yet. Not a verdict.</td></tr><tr><td><span class="pk-badge pk-badge--orange">Needs review</span></td><td>Incomplete, inconsistent or implausible extraction, or a failed replication; the values are unverified.</td></tr><tr><td><span class="pk-badge pk-badge--red">Rejected</span></td><td>Not accepted; the values are shown for inspection only.</td></tr><tr><td><span class="pk-badge pk-badge--stale">stale</span></td><td>Reviewed before the paper was last screened; a new review is pending, so the status comes from the automatic checks.</td></tr><tr><td><span class="pk-badge pk-badge--green">cross-checked ✓</span></td><td>All responding readers agree on all compared fields; fractions indicate agreeing/total readers.</td></tr><tr><td><span class="pk-badge pk-badge--orange">cross-check: partial</span></td><td>At least one non-structural discrepancy or incomplete reader agreement.</td></tr><tr><td><span class="pk-badge pk-badge--red">cross-check: disputed</span></td><td>At least one structural-parameter discrepancy; primary extraction retained pending review.</td></tr><tr><td><span class="pk-badge pk-badge--species">rat</span></td><td>Non-human or in-vitro evidence; parameters and simulations describe the stated experimental system.</td></tr></tbody></table>
<p><small><b>Status</b> reports validation and review outcomes; <b>cross-check</b> reports agreement between independent extractions. Agreement does not establish plausibility, model validity, or clinical applicability.</small></p>
</details>

### Reviewer guidance

**No value for nadroparin's clearance, volume of distribution and absorption lag time.**

The model was built, but nadroparin's clearance, volume of distribution and absorption lag time had no value, so a library placeholder stood in and the model was held back rather than published with an invented number. Extracted — nadroparin: CL/F 0.211 L/h, V/F 1.55 L, kabs 0.495 h-1.

A second, independent reading of the paper (`gpt-oss-120b`) disagrees on which molecule was measured: this record has anti-Xa, the second reading unknown. That field shapes the model, so the record is marked disputed.

<sub>reviewed by rule template (no LLM)</sub>

### All parameter columns

| label (paper) | Q-code · name | value | unit | value_si | unit_si | unit_canonical | link | source | IIV |
|---|---|---|---|---|---|---|---|---|---|
| CL/F (L/h) | `Q27` · CL/F | 0.211 | L/h | 5.861e-08 | m3/s | l/h | exact (1) | T2:row3:col1, T2:row3:col2, T2:row3:col3, T2:row3:col4 | 26.5 (None% RSE) |
| Vd/F (L) | `Q76` · V/F | 1.55 | L | 0.00155 | m3 | l | exact (1) | T2:row4:col1, T2:row4:col2, T2:row4:col3, T2:row4:col4 |  |
| ka (h-1) | `Q49` · kabs | 0.495 | h-1 | 0.0001375 | 1/s | 1/h | exact (1) | T2:row5:col1, T2:row5:col2, T2:row5:col3, T2:row5:col4 |  |

<details class="legend">
<summary>Parameter definitions</summary>
<table><thead><tr><th>Field</th><th>Definition</th></tr></thead><tbody><tr><td><code>label (paper)</code></td><td>Verbatim source label (label_verbatim).</td></tr><tr><td><code>Q-code · name</code></td><td>Matched ontology identifier and parameter name; e.g. Q22: clearance, Q27: CL/F, Q49: ka.</td></tr><tr><td><code>value</code></td><td>Reported parameter estimate.</td></tr><tr><td><code>unit</code></td><td>Verbatim source unit (unit_verbatim).</td></tr><tr><td><code>value_si</code></td><td>Normalised estimate in SI base units, 4 significant figures; absent when unit conversion is unavailable.</td></tr><tr><td><code>unit_si</code></td><td>SI unit of value_si (m3/s for a clearance, m3 for a volume, 1/s for a rate constant, s for a time).</td></tr><tr><td><code>unit_canonical</code></td><td>Canonical unit associated with the parameter's Q-code.</td></tr><tr><td><code>link</code></td><td>Ontology-mapping method and confidence. exact/boundary/fuzzy/tv_prefix/caption_compartment/special_case: deterministic; llm/llm_confirmed/llm_corrected: LLM-assisted; review/review_gapfill: secondary-review source; boundary_relink: corrected mapping.</td></tr><tr><td><code>source</code></td><td>Source location: colN (table column), other_prose (text), review (secondary source), or pgx (PGx record).</td></tr><tr><td><code>IIV</code></td><td>Reported interindividual variability.</td></tr><tr><th colspan="2" style="text-align:left;padding-top:10px">placeholders</th></tr><tr><td><code>(empty cell)</code></td><td>Not recorded; not equivalent to zero. A column empty in every row is not shown.</td></tr><tr><td><code>—</code></td><td>Not applicable or not displayed.</td></tr><tr><td><code>not verified</code></td><td>Record not accepted; displayed estimates remain unverified.</td></tr></tbody></table>
</details>

## Departures & gaps

**Interpretation flags:**
- table section iiv: 'CL/F' routed out of structural estimates ('Inter-individual variability (%CV)')
- table section residual_error: 'Proportional residual error' routed out of structural estimates ('Residual variability (%CV)')
- dropped duplicate Q27 ('CL/F_CLCR', value '0.238') — already have one for this compound
- apparent-ness (ontology-grounded): parameterization=apparent, measured_compound=anti-Xa
- molar mass: no plausible PubChem entry for 'anti-Xa' ('anti-factor Xa activity') — left in mass units
- molar mass: none found for 'nadroparin' — its concentrations stay mass-only
- molar mass: none found for 'anti-Xa' — its concentrations stay mass-only
- review gap-fill skipped: this record measures 'anti-Xa', not nadroparin — the review values are the parent's

**Extraction notes:**
- LLM selected parameter table(s) 2

## Validation

**Cross-check (independent readings):** <span class="pk-badge pk-badge--red">cross-check: disputed</span>  
Primary extraction: `qwen3.8-27b`; retained regardless of cross-check verdict.

| second reader | verdict | agreement | disagreements |
|---|---|---|---|
| `gpt-oss-120b` | not confirmed | 0.857 (6/7 fields) | 1 |

<details><summary>1 field discrepancy</summary>

| second reader | field | first reading | second reading | agreement |
|---|---|---|---|---|
| `gpt-oss-120b` | `screen.primary_analyte` | anti-Xa | unknown | mismatch |

</details>

<details class="legend">
<summary>Cross-check definitions</summary>
<table><thead><tr><th>Field</th><th>Definition</th></tr></thead><tbody><tr><td><code>second reader</code></td><td>Additional extraction model; the default uses a different model family. Multiple readers are supported.</td></tr><tr><td><code>agreement</code></td><td>Proportion of compared fields in agreement.</td></tr><tr><td><code>verdict</code></td><td>confirmed: full agreement; partly confirmed: non-structural discrepancy; not confirmed: structural discrepancy; primary re-run: hinted retry after an empty primary extraction.</td></tr><tr><td><code>combined</code></td><td>Confirmed only when all responding readers agree; a structural discrepancy makes the result disputed.</td></tr><tr><td><code>kept</code></td><td>Primary extraction retained; discrepancies require review rather than automatic replacement.</td></tr></tbody></table>
</details>


**Scholar closed-form checks:**

| check | status | expected | obtained | source |
|---|---|---|---|---|
| C0_has_structural_params | pass |  | 3 |  |
| C0b_disposition_core | pass |  |  |  |
| C0c_disposition_complete | pass |  |  |  |
| C5_dimension_Q27 | pass | [length] ** 3 / [time] |  | ['T2:row3:col1', 'T2:row3:col2', 'T2:row3:col3', 'T2:row3:col4'] |
| C5_dimension_Q49 | pass | 1 / [time] |  | ['T2:row5:col1', 'T2:row5:col2', 'T2:row5:col3', 'T2:row5:col4'] |
| C5_dimension_Q76 | pass | [length] ** 3 |  | ['T2:row4:col1', 'T2:row4:col2', 'T2:row4:col3', 'T2:row4:col4'] |
| C7_apparent_coherence | pass |  |  |  |
| C8_topology | pass |  |  |  |
| C9_phys_window_Q27 | pass | clearance within physiological range | 0.211 L/h | ['T2:row3:col1', 'T2:row3:col2', 'T2:row3:col3', 'T2:row3:col4'] |
| C9_phys_window_Q76 | pass | volume within physiological range | 1.55 L | ['T2:row4:col1', 'T2:row4:col2', 'T2:row4:col3', 'T2:row4:col4'] |

**Reviewer per-scenario checks:**

| check | status | expected | obtained | note |
|---|---|---|---|---|
| T0_analyte_identity | pass |  |  | V/CL labels are the drug's (or a metabolite's), no biomarker signal |
| T2_covariates | skipped |  |  | no covariate effects in record |
| T3_apparent_invariant | pass |  | F=Fm=1, no molar correction | apparent params must not be double-corrected |
| T3_param_coverage | pass | 3 scholar param(s) emitted or defaulted | 3 covered | all structural parameters accounted for |
| T3_topology_template | pass | 1C → PK_1C* | PK_1C_enteral | engineer template must match the scholar topology |
| T6_deviations | pass |  | all deviations documented+quantified | LLM adjudication → deterministic rule |

<details class="legend">
<summary>Validation definitions</summary>
<table><thead><tr><th>Field</th><th>Definition</th></tr></thead><tbody><tr><td><code>check</code></td><td>Validation identifier. C0: structural parameters; C0b: volume or clearance/elimination; C0c: both; C1: half-life consistency; C2: covariate-effect plausibility; C3: clearance–dose–AUC consistency; C4: analytic AUC; C5: dimensional consistency.</td></tr><tr><td><code>status</code></td><td>pass, fail, or skipped. Skipped checks lack required inputs and provide no validation evidence.</td></tr><tr><td><code>expected</code></td><td>Source- or ontology-derived reference value.</td></tr><tr><td><code>obtained</code></td><td>Value derived from the extracted record or simulation.</td></tr><tr><td><code>ratio</code></td><td>Obtained/reference value.</td></tr><tr><td><code>tol</code></td><td>Acceptance tolerance.</td></tr><tr><td><code>source</code></td><td>Reference-value provenance.</td></tr><tr><td><code>scenario</code></td><td>Evaluated covariate scenario (reviewer checks).</td></tr><tr><td><code>note</code></td><td>Evaluation or exclusion rationale.</td></tr><tr><th colspan="2" style="text-align:left;padding-top:10px">placeholders</th></tr><tr><td><code>(empty cell)</code></td><td>Not recorded; not equivalent to zero. A column empty in every row is not shown.</td></tr><tr><td><code>—</code></td><td>Not applicable or not displayed.</td></tr><tr><td><code>not verified</code></td><td>Record not accepted; displayed estimates remain unverified.</td></tr></tbody></table>
</details>


</details>

<div class="pk-tab-mark" data-tab="Models"></div>

## Model downloads

<div class="pk-models-grid"><div class="pk-models-table">
<table class="pk-models"><thead><tr><th>format</th><th>archive contents</th><th>download</th></tr></thead><tbody>
<tr><td><b>Modelica</b></td><td><code>.mo</code> + Modelica script</td><td><span class="pk-missing">unavailable</span></td></tr>
<tr><td><b>FMI 2.0 (FMU)</b></td><td><code>.fmu</code> + fmpy driver</td><td><span class="pk-missing">unavailable</span></td></tr>
<tr><td><b>MATLAB &amp; GNU Octave</b></td><td><code>.m</code> ODE function + driver</td><td><a href="drugs/drug_nadroparin/Nadroparin_Chen2024_reference/Nadroparin_Chen2024_reference_matlab.zip" download>Nadroparin_Chen2024_reference_matlab.zip</a> <span class="pk-size">(3.2 kB)</span></td></tr>
<tr><td><b>MATLAB (SimBiology)</b></td><td><code>.sbproj</code> + driver</td><td><a href="drugs/drug_nadroparin/Nadroparin_Chen2024_reference/Nadroparin_Chen2024_reference_matlab_simbio.zip" download>Nadroparin_Chen2024_reference_matlab_simbio.zip</a> <span class="pk-size">(3.0 kB)</span></td></tr>
<tr><td><b>SBML</b></td><td><code>.xml</code> (L3V2) + Python driver</td><td><a href="drugs/drug_nadroparin/Nadroparin_Chen2024_reference/Nadroparin_Chen2024_reference_sbml.zip" download>Nadroparin_Chen2024_reference_sbml.zip</a> <span class="pk-size">(2.4 kB)</span></td></tr>
<tr><td><b>CellML</b></td><td><code>.cellml</code> + Python driver</td><td><a href="drugs/drug_nadroparin/Nadroparin_Chen2024_reference/Nadroparin_Chen2024_reference_cellml.zip" download>Nadroparin_Chen2024_reference_cellml.zip</a> <span class="pk-size">(2.9 kB)</span></td></tr>
</tbody></table>
<p>Archives contain model source, a simulation script, and execution instructions.</p>
</div></div>

## How to cite

**Source paper** (the parameters are its): Chen Y, Lan J, Zhu L, Dong M, Wang Y, Li Z. Is the current therapeutic dosage of nadroparin adequate for neonates and infants under 8 months with thromboembolic disease? a population pharmacokinetic study from a national children's medical center. Frontiers in pharmacology 15:1331673 (2024). [doi:10.3389/fphar.2024.1331673](https://doi.org/10.3389/fphar.2024.1331673)

**This record:** Pharmacolibrary v26.09, model `Nadroparin_Chen2024_reference`. <https://pharmacolibrary.github.io/#/drugs/drug_nadroparin/Nadroparin_Chen2024_reference>

```bibtex
@misc{pharmacolibrary_NadroparinChen2024reference,
  title  = {{Pharmacolibrary model Nadroparin_Chen2024_reference}},
  author = {{Pharmacolibrary}},
  version = {v26.09},
  url    = {https://pharmacolibrary.github.io/#/drugs/drug_nadroparin/Nadroparin_Chen2024_reference},
  note   = {Parameters from doi:10.3389/fphar.2024.1331673},
}
```

Licence of the model files: not set yet. The parameter values belong to the cited paper.

<div class="pk-tab-mark" data-tab="Simulation"></div>

_Browser simulation unavailable: no shared WebAssembly template. The **Models** tab provides the record-specific FMI archive._

<div class="pk-tab-end"></div>

---
<sub>Research data extracted by software from published papers; not clinically validated and not for dosing decisions. [Report a problem with this record](https://github.com/pharmacolibrary/pharmacolibrary.github.io/issues/new?title=%5Bnadroparin%5D%20Nadroparin_Chen2024_reference&body=Drug%3A%20nadroparin%0ARecord%3A%20Nadroparin_Chen2024_reference%0APaper%3A%20Chen_2024%0APage%3A%20https%3A//pharmacolibrary.github.io/%23/drugs/drug_nadroparin/Nadroparin_Chen2024_reference%0ABuild%3A%20v26.09%0A%0AWhat%20is%20wrong%3A%0A)</sub>  
<sub>Pharmacolibrary v26.09 · extracted 2026-10-07 18:12 UTC</sub>
